gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
A method for treating a disease.
|
gptkbp:applicationNumber
|
10/775,123
|
gptkbp:applicationType
|
non-provisional
|
gptkbp:assignee
|
gptkb:ABC_Corporation
|
gptkbp:assigneeCountry
|
gptkb:USA
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:class
|
C12N
|
gptkbp:country
|
gptkb:United_States
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
2024-01-30
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
gptkbp:fieldOfUse
|
medical treatment
|
gptkbp:filingDate
|
2004-01-30
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,011 C61
|
gptkbp:internationalClassification
|
C12N 15/09
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:inventorCountry
|
gptkb:USA
|
gptkbp:issueDate
|
2004-09-14
|
gptkbp:issuedBy
|
gptkb:United_States_Patent_and_Trademark_Office
|
gptkbp:language
|
English
|
gptkbp:legalStatus
|
granted
|
gptkbp:location
|
gptkb:Washington,_D.C.
|
gptkbp:notableFeature
|
novel compound
|
gptkbp:patentCitation
|
gptkb:US_6,789,014_C3
gptkb:US_6,789,013_C2
gptkb:US_5,678,901_A
gptkb:US_6,543,210_B1
gptkb:US_6,789,012_D1
gptkb:US_6,789,028_C17
gptkb:US_6,789,025_C14
gptkb:US_6,789,019_C8
gptkb:US_6,789,021_C10
gptkb:US_6,789,022_C11
gptkb:US_6,789,020_C9
gptkb:US_6,789,026_C15
gptkb:US_6,789,031_C20
gptkb:US_6,789,027_C16
gptkb:US_6,789,015_C4
gptkb:US_6,789,029_C18
gptkb:US_6,789,018_C7
gptkb:US_6,789,017_C6
US 6,789,024 C13
US_6,789,016_C5
US_6,789,023_C12
US_6,789,030_C19
|
gptkbp:patentFamily
|
US_6,789,011_C61,_US_7,123,456_B2
|
gptkbp:patentNumber
|
6,789,011
|
gptkbp:patentType
|
utility
|
gptkbp:priorityDate
|
2003-01-30
|
gptkbp:publications
|
patent grant
|
gptkbp:relatedTo
|
gptkb:US_6,123,456_A1
|
gptkbp:researchField
|
biotechnology
|
gptkbp:status
|
active
|
gptkbp:subclass
|
C12N_15/00
|